Clinical Trial Update: VH3739937 Phase 1 Multiple Ascending Dose (MAD) Study in Healthy Volunteers Including Relative Bioavailability (RBA), Optional Food Effect (FE), and Drug-drug Interaction (DDI) [Phase 1]

View source ↗

Summary

Phase 1 MAD study of VH3739937 in healthy volunteers has been withdrawn, including assessments of relative bioavailability, food effect, and drug-drug interacti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• VH3739937

Snippet

Sponsor: ViiV Healthcare | Conditions: HIV Infections | Phase 1 | Status: WITHDRAWN